Moderate Reaction to Lanxess' Quarterly Figures: Analysts' Attitude Remains Unchanged

The analysts at Jefferies have not revised their judgment on Lanxess even after the company presented its latest quarterly figures. Despite an operating result that largely met market expectations, the analysis firm maintains its 'Hold' rating and a target price of 26 euros. In a current analyst comment, Chris Counihan points out that the adjusted EBITDA of the specialty chemicals company has almost fulfilled both the internally set forecasts and the average market projections. Despite this accuracy in meeting predictions, Lanxess seems to be somewhat cautious regarding financial outlook. The forecast for the adjusted EBITDA for both the first quarter and for the full year 2024 was below expectations. This conservative perspective could, according to Counihan, lead to a downward pressure on the company's share prices at the start of trading. Investors and market participants will now wait to see how this cautious stance will affect Lanxess's business development in the current fiscal year and to what extent this is already priced into the current share price.